Department of Nanomedicine

The Department of Nanomedicine focuses on interdisciplinary research by combining nanoengineering, mathematical modeling and biomedical sciences to develop nanotechnology-enabled therapeutic and diagnostic platforms for combating diseases including cancer, cardiovascular diseases and infectious diseases. Our research spans a wide range of areas including personalized nanochannel drug delivery systems, injectable nanovectors that achieve desired therapeutic concentrations in target tissue, discovery of new protein biomarkers through proteomics, developing biodegradable synthetic polymers with the biological functions of natural biomaterial scaffolds, and microfluidics for disease diagnostics.
Methodist in Space

Houston Methodist received about $1.25 million from the Center for the Advancement of Science in Space (CASIS) to develop an implantable device that delivers therapeutic drugs at a rate guided by remote control. Learn more.

Department Chair

Alessandro Grattoni, PhD
Assistant Professor of Nanomedicine, Institute for Academic Medicine
Chair, Department of Nanomedicine
Houston Methodist

R&D 100 Awards Finalist

Houston Methodist's single-cell pipette device has been selected as a finalist for the 2015 R&D 100 Award which recognizes the 100 most technologically significant products introduced in the past year. Congratulations to the inventors Lidong Qin, PhD, Kai Zhang, PhD, and Sharon Li. Learn more.


Department of Nanomedicine
Houston Methodist Research Institute
6670 Bertner Ave.
Houston, TX 77030